UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005342 |
|---|---|
| Receipt number | R000006306 |
| Scientific Title | Randomized phase II trial of CODE or amrubicin and cisplatin chemotherapy following concurrent cisplatin, etoposide and accelerated hyperfractionation thoracic radiotherapy for limited disease small cell lung cancer (JCOG1011, LD-SCLC/CODE vs AP) |
| Date of disclosure of the study information | 2011/03/30 |
| Last modified on | 2022/08/30 16:12:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/03/30 09:16:55 | ||
| 2 | Update | 2011/05/27 12:48:18 | Organization1 Address1 Tel1 Email1 |
|
| 3 | Update | 2012/05/25 14:27:29 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 4 | Update | 2012/06/20 11:35:51 | Acronym Acronym |
|
| 5 | Update | 2012/06/20 16:09:36 | Institutions |
|
| 6 | Update | 2012/12/27 15:52:50 | Developmental phase |
|
| 7 | Update | 2012/12/27 15:56:20 | Developmental phase |
|
| 8 | Update | 2013/04/09 11:20:30 | Name of person sending information Name of person sending information |
|
| 9 | Update | 2014/01/24 17:05:33 | Recruitment status |
|
| 10 | Update | 2014/01/24 17:06:59 | TEL |
|
| 11 | Update | 2014/01/24 17:07:51 | Recruitment status |
|
| 12 | Update | 2014/01/24 17:08:26 | Recruitment status |
|
| 13 | Update | 2014/02/17 15:35:45 | Recruitment status |
|
| 14 | Update | 2017/11/07 18:27:46 | Recruitment status Anticipated trial start date Publication of results URL related to results and publications Results Results |
|
| 15 | Update | 2022/08/30 16:12:45 | Recruitment status Date of IRB |
